Actively Recruiting
Developing a Clinical Outcome Assessment for Opioid Craving
Led by Johns Hopkins University · Updated on 2025-10-23
81
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to collect information about opioid craving so that the investigators can develop an opioid craving assessment to improve treatments for individuals with opioid use disorder. To collect this information, the investigators are recruiting individuals in treatment for opioid use disorder who will complete cue-induced opioid craving tasks where these individuals will: (1) look at pictures of neutral objects and touch neutral objects (e.g., water bottles or flashlights), (2) look at opioid-related images, and (3) look and touch opioid-related objects. Participants will then complete a one-on-one interview about the thoughts, feelings and physical sensations the participants experienced during the cue-induced craving session. Participants will also complete questionnaires and existing opioid craving assessments. Finally, participants will provide formal feedback about existing opioid craving assessments with cognitive interviews.
CONDITIONS
Official Title
Developing a Clinical Outcome Assessment for Opioid Craving
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Opioid-positive urine sample at admission visit (excluding individuals receiving Naltrexone)
- Current opioid use disorder diagnosed by DSM-5
- Currently in treatment for opioid use disorder
You will not qualify if you...
- Pregnant, breastfeeding, or may become pregnant during the trial
- History of psychosis, mania, or other serious psychiatric disorders
- Suicidal behavior in the past 30 days
- Circumstances interfering with study participation (e.g., impending jail)
- Positive for illicit substances other than opioids and cannabis
- Current substance use disorder other than opioid or nicotine
- Current intoxication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Behavioral Pharmacology Research Unit
Baltimore, Maryland, United States, 21224
Actively Recruiting
Research Team
C
Cecilia L Bergeria, PhD
CONTACT
K
Kelly Dunn, Ph.D., M.B.A.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here